-
Royal Society of Chemistry and Cogent offer £400,000 Talent Recruitment Grant Funding
Royal Society of Chemistry and Cogent combine forces on future talent recruitment incentives providing £400,000 in grants for companies to provide higher apprenticeship training for employees and to host industrial placements.
-
PharmApprove, Leading Regulatory and Scientific Communications Firm, Expands in Europe
PharmApprove, Leading Regulatory and Scientific Communications Firm, Expands in Europe, Coos De Graaf Named New Head of European Operations
-
Selcia celebrates success of MHRA inspection of GMP Radiolabelling facility
Selcia celebrates the success of a recent inspection of its GMP Radiolabelling facility by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
-
New ground-breaking IVF Technology now available at IVF Spain in Alicante
IVF Spain is offering Early Embryo Viability Assessment (Eeva™) test. Eeva Designed to Improve IVF Outcomes.
-
Renowned UK IVF clinic reflects on success with Eeva™
Renowned UK IVF clinic reflects on success with Eeva™. Enhanced patient experience a key benefit of new IVF technology.
-
UK’s first home test for hereditary breast cancer
Women at risk of hereditary breast cancer are being offered a speedy test and expert consultation over the phone in a unique and revolutionary new service.
-
Record Levels of Foreign Direct Investment in London – LBIC News
The London Bioscience Innovation Centre’s LBIC Newsletter for Autumn 2013 out today examines how London’s position as a global leader in science and technology is leading to record levels of foreign direct investment (FDI).
-
Fujifilm Diosynth Biotechnologies Opens New Manufacturing Facility
Fujifilm Diosynth Biotechnologies today formally opened its new mammalian cell culture cGMP manufacturing facility at a ceremony performed by HRH The Duke of Gloucester.
-
to-BBB Presents Clinical Data on Lead Product 2B3-101
to-BBB presents clinical data on lead product 2B3-101, a potential new treatment option for patients with brain cancer an active transport processes at the blood-brain barrier.
-
Cambridge Research Biochemicals acquires rights to novel drug therapy technology
Cambridge Research Biochemicals acquires rights to novel technology useful for development of gene and drug therapies